SomaLogic, Inc. financial data

Industry
Services-Commercial Physical & Biological Research
Location
C/O Somalogic, Inc., 2945 Wilderness Place, Boulder, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
CM Life Sciences II Inc. (to 9/1/2021)
Latest financial report
10-Q - Q3 2023 - Nov 8, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.51K % -23.6%
Quick Ratio 41 % -14.8%
Debt-to-equity 14.4 % -1.24%
Return On Equity -24.7 % -81.1%
Return On Assets -21.6 % -81.4%
Operating Margin -188 % -28.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 188M shares +0.29%
Common Stock, Shares, Outstanding 189M shares +0.62%
Entity Public Float 648M USD
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 187M shares +1.44%
Weighted Average Number of Shares Outstanding, Diluted 187M shares +1.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 81.7M USD -19.7%
Research and Development Expense 57.9M USD -6.64%
Operating Income (Loss) -154M USD -2.82%
Nonoperating Income (Expense) 23.8M USD -63.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -130M USD +35.4%
Income Tax Expense (Benefit) 375K USD
Net Income (Loss) Attributable to Parent -130M USD -56.7%
Earnings Per Share, Basic -0.69 USD/shares -46.8%
Earnings Per Share, Diluted -0.69 USD/shares -46.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 306M USD -19.7%
Accounts Receivable, after Allowance for Credit Loss, Current 20.7M USD -17.2%
Inventory, Net 13.9M USD -24.9%
Assets, Current 494M USD -20.5%
Property, Plant and Equipment, Net 18.2M USD -8.73%
Operating Lease, Right-of-Use Asset 4.3M USD
Goodwill 10.4M USD -0.63%
Other Assets, Noncurrent 5.87M USD +2.73%
Assets 565M USD -17.9%
Accounts Payable, Current 11.5M USD -43.5%
Contract with Customer, Liability, Current 3.07M USD -14.9%
Liabilities, Current 27.8M USD -34.9%
Contract with Customer, Liability, Noncurrent 30.9M USD -3.35%
Operating Lease, Liability, Noncurrent 2.76M USD +2.71%
Other Liabilities, Noncurrent 7.27M USD +18.9%
Liabilities 68.3M USD -20.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14K USD +98.6%
Retained Earnings (Accumulated Deficit) -690M USD -23.4%
Stockholders' Equity Attributable to Parent 497M USD -17.6%
Liabilities and Equity 565M USD -17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -43M USD -628%
Net Cash Provided by (Used in) Financing Activities 172K USD -86.2%
Net Cash Provided by (Used in) Investing Activities 55.3M USD +650%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 189M shares +0.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12.4M USD +362%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 307M USD -20.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 169M USD +27.4%
Deferred Tax Assets, Gross 174M USD +30.7%
Operating Lease, Liability 4.73M USD -7.83%
Payments to Acquire Property, Plant, and Equipment 1.26M USD +247%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -129M USD -53.8%
Lessee, Operating Lease, Liability, to be Paid 5.03M USD -5.26%
Property, Plant and Equipment, Gross 37.5M USD +51.1%
Operating Lease, Liability, Current 1.97M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.59M USD +38.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.88M USD -26.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +83.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 293K USD +72.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 920K USD +10.3%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +6.77%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 1.48M USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 143K USD
Operating Lease, Payments 600K USD +20%
Additional Paid in Capital 1.19B USD +2.06%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.75M USD +132%
Deferred Tax Assets, Net of Valuation Allowance 4.44M USD
Share-based Payment Arrangement, Expense 24.1M USD -43.7%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%